Literature DB >> 11382259

Pain outcome measures.

R A Scudds1.   

Abstract

Pain is a complex, multi-dimensional experience that is usually associated with local tissue damage or may be referred from a distant site. Classically, pain is viewed as having sensory, affective, and cognitive components. To assess pain, however, the clinician or the researcher must use the most appropriate measure for the given situation. Many pain outcome measures are currently in use. Some of these are simple uni-dimensional scales, whereas others adopt a more multi-dimensional approach. Pain is rarely measured in isolation but must instead be put into the context of the whole person and that person's functional ability. All these factors should be borne in mind in the evaluation of pain in the hand. This paper discusses pain measurement instruments and makes recommendations for assessment of pain in the hand.

Entities:  

Mesh:

Year:  2001        PMID: 11382259     DOI: 10.1016/s0894-1130(01)80038-7

Source DB:  PubMed          Journal:  J Hand Ther        ISSN: 0894-1130            Impact factor:   1.950


  3 in total

1.  Astym treatment vs. eccentric exercise for lateral elbow tendinopathy: a randomized controlled clinical trial.

Authors:  Thomas L Sevier; Caroline W Stegink-Jansen
Journal:  PeerJ       Date:  2015-05-19       Impact factor: 2.984

2.  Study on the efficacy and safety of the combination of Shi's manual therapy and percutaneous endoscopic lumbar diskectomy for lumbar disc herniation with radiculopathy: study protocol for a multicenter randomized controlled trial.

Authors:  Huihao Wang; Weian Yuan; Zhongxiang Yu; Xiang Wang; Xinxin Zhao; Zhen Deng; Guangyue Yang; Weinan Chen; Zhibi Shen; Hongsheng Zhan
Journal:  Trials       Date:  2022-04-23       Impact factor: 2.728

3.  Efficacy of manual therapy treatments for people with cervicogenic dizziness and pain: protocol of a randomised controlled trial.

Authors:  Susan A Reid; Darren A Rivett; Michael G Katekar; Robin Callister
Journal:  BMC Musculoskelet Disord       Date:  2012-10-18       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.